DOCSLIB.ORG

(12) Patent Application Publication (10) Pub. No.: US 2008/0261923 A1 Etzkorn Et Al

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
(12) Patent Application Publication (10) Pub. No.: US 2008/0261923 A1 Etzkorn Et Al US 20080261923A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2008/0261923 A1 Etzkorn et al. (43) Pub. Date: Oct. 23, 2008 54) ALKENE MIMICS Related U.S. Applicationpp Data (76) Inventors: Felicia A. Etzkorn, Blacksburg, VA (60) Provisional application No. 60/598.421, filed on Aug. (US); Xiaodong X. Wang, 4, 2004. Maricopa, AZ (US); Bulling Xu, Publication Classification Blacksburg, VA (US) (51) Int. Cl. Correspondence Address: A63/675 (2006.01) WHITHAM, CURTIS & CHRISTOFFERSON & C07F 9/06 (2006.01) COOK, PC A6IP35/00 (2006.01) 9 Lew e 11491 SUNSET HILLS ROAD, SUITE 340 A6II 3/662 (2006.01) RESTON, VA 20190 (US) (52) U.S. Cl. ............... 514/80; 546/22: 548/414: 546/23; 548/112:558/166; 514/89: 514/114 (22) PCT Filed: Jul. 29, 2005 Ac-Phe-Tyr-phosphoSer-CH=C-Pro-Arg-NHAND Fmoc-bis(pivaloylmethoxy)phosphoSer-CH=C-Pro-2- (86). PCT No.: PCT/USOS/26821 aminoethyl-(3-indole); and their Phospho-(D)-serine stereoi Somers are novel compounds. I refers to a pseudo amide. S371 (c)(1), Such novel compounds advantageously may be used as alk (2), (4) Date: Sep. 26, 2007 ene mimics. US 2008/0261923 A1 Oct. 23, 2008 ALKENE MIMICS 0005. The possibility of Pin1 activity led to interest and work on certain alkene mimics. (Wang, Supra); Wang, X. J., FIELD OF THE INVENTION Xu, B., Mullins, A. B., Neiler, F.K., and Etzkorn, F.A. (2004), Conformationally Locked Isostere of PhosphoSer-cis-Pro 0001. This invention relates to the design and synthesis of Inhibits Pin1 23-Fold Better than PhosphoSer-trans-Pro Isos compounds that are alkene mimics. tere, J. Am. Chem. Soc. 126, 15533-15542. 0006. However, relatively few inhibitors of Pin1 are BACKGROUND OF THE INVENTION known, and Pin1 inhibitors with greater inhibitory activity 0002 Certain small molecules were designed to mimic would be desirable for medical applications. (Hennig, Supra); peptides in order to determine which amide form is critical to Uchida, T., Takamiya, M., Takahashi, M., Miyashita, H., the biological function of peptidyl-prolyl isomerases (PPI Ikeda, H., Terada, T., Matsuo.Y., Shirouzu, M.Yokoyama, S., ases). Such as cyclophilin, with particular attention to (Z)- Fujimori, F., and Hunter, T. (2003), Pin1 and Par14 peptidyl alkene mimics. Hart and Etzkorn (2000); Hart, Trindle and prolyl isomerase inhibitors block cell proliferation, Chem. Etzkorn (2001). In about April 2002, drug design to stop the Biol. 10, 15-24. cancer cell cycle was under consideration, and the cell-cycle 0007. The reversible phosphorylation of proteins is the regulating enzyme, Pin1, was targeted, with an eye towards most important posttranslational modification that occurs in anticancer activity. (Virginia Tech Press release dated Apr. 10, the cell. It is also the most efficient and versatile signal of 2002, “Chemists Explore the Shape of the Key that Signals intermolecular communication. As a result, many drug tar Cell Division in Cancer Cells). At that time, the single known gets show high-affinity interactions with phosphorylated inhibitor of Pin1 was a natural product, juglone, that is not molecules, while their unphosphorylated counterparts are not specific for Pin1 and is a poor inhibitor. Hennig, L., Christner, stable for binding to the targets. However, there is a problem C., Kipping, M., Schelbert, B., Rucknagel, K. P. Grabley, S., for these phosphorylated molecules: unprotected phosphory Kullertz, G., and Fischer, G. (1998), Selective inactivation of lated compounds are not effective at penetrating cell mem parvulin-like peptidyl-prolyl cis/trans isomerases by juglone, branes, thus are not bioactive because of the negative charges Biochemistry 37, 5953-5960. on phosphate groups. One general approach to this problem 0003) Regulation of the cell cycle is of fundamental sig involves masking the phosphate in a form that neutralizes nificance in developmental biology and gives rise to cancer their negative charges. Among the reversibly masking phos when it goes awry. The enzyme Pin1 is a phosphorylation phate compounds, a bis-pivaloyloxymethyl strategy is espe dependent peptidyl-prolyl isomerase (PPIase) enzyme cially useful since such compounds are quite stable in buffer thought to regulate mitosis via cis-trans isomerization of and plasma and they are readily transformed to free phosphate phosphoSer-Pro amide bonds in a variety of cell cycle pro inside various cell types. Scheme 1 below shows the mecha teins. Lu, K. P. Hanes, S. D., and Hunter, T. (1996). A human nism for degradation of bis(POM) phosphate inside cells. peptidyl-prolyl isomerase essential for regulation of mitosis, Nature 380, 544-547; Yaffe, M. B., Schutkowski, M., Shen, Scheme 1: Degradation of Bis(POM) phosphate inside cell M., Zhou, X. Z., Stukenberg, P. T. Rahfeld, J.-U., Xu, J., Kuang, J., Kirshcner, M. W. Fischer, G., Cantley, L. C., and Lu, K. P. Science 278 (1997) 1957. In particular, Pin1 has been shown to bind phosphoSer-Pro epitopes in cdc25 phos phatase, a key regulator of the cdc2/cyclinB complex. King, R. W., Jackson, P. K., and Kirschner, M. W., Cell 79 (1994) 563. The central role Pin1 plays in the cell cycle makes Pin1 an interesting target for inhibition, both for potential anti cancer activity and for elucidation of the mechanism of mito RO-P sis regulation. It has been proposed that Pin1 recognition of the phosphoSer-Pro amide bond acts as a conformational So-ci-o-o-chO switch in the cell cycle. Shen, M., Stukenberg, P. T., Kir schner, M. W., and Lu, K. P. Genes Dev. 12 (1998) 706. HCHO 0004 Preference for phosphorylated substrates by Pin1 HG) has been clearly demonstrated (Yaffe, supra), with the central dipeptide phosphoSer-Pro as the primary recognition ele O e ment. Successful laboratory work has been accomplished O9 phosphodiesterase RO- !{O using a (Z)-alkene amide bond isostere to mimic the Ala-cis RO-Ke o-CH-O--CH, Pro amide bond for the inhibition of the PPIase cyclophilin, O which then led to design of an analogous inhibitor based on a substrate for Pin1. Hart, S.A., Sabat, M., and Etzkorn, F. A., J. Org. Chem. 63 (1998)7580; Hart, S.A., and Etzkorn, F.A., J. Org. Chem. 64 (1999) 2298. Synthesis of the Boc-Ser /sterse (Z)CH=C-Pro mimic proceeded with regio- and enantio selectivity through a 2.3-sigmatropic rearrangement. Wang, -HCHO X. J., Hart, S.A., Xu, B., Mason, M.D., Goodell, J. R., and HG) O Etzkorn, F. A. (2003), Serine-cis-proline and Serine-trans o proline Isosteres: Stereoselective Synthesis of (Z)- and (E)- RO-PQ Alkene Mimics by Still-Wittig and Ireland-Claisen Rear O-CH-OH rangements, J. Org. Chem. 68, 2343-2349. US 2008/0261923 A1 Oct. 23, 2008 0008 Scheme 1: Degradation of Bis(POM) phosphate inside cell During the process, two different degradation -continued enzymes are involved: esterase and phosphodiesterase. Thus, after the cell entry, the mask for the phosphate group is removed and the compounds converted to a biologically O. O active form. Three methods have been described to introduce \\ the bispivaloyloxymethyl(POM) phosphate triesters. Scheme o1 No 2 below shows three methods. Scheme 2: Three methods to introduce Bis(POM) phosphate n 2 H Method 1. H N NR 1) iPrNP(OBn) O ROH 1H-tetrazole l-OBn H2, Pd/C O 2) MCPBA R-O-PQ phosphoSer-I(E)CHFCPro compounds OB OH POMI OPOM R-O- K DIPEA, MeCN R-O- K wherein R is a carbonyl group attached to the amine as an OH OPOM amide, and R is an amine attached to the carbonyl as an Method 2. amide. 1) POCl3/EtN 0012 Another preferred embodiment of the invention pro PO(OMe) vides an alkene compound which is a phospho-(D)-serine RCH2OH mimic, wherein the phospho-(D)-serine mimic is selected GE) from the group consisting of O G5 INEt3 POMCI, EtN O|OPOM RCHO-PQe1 Her RCH-O-PQ1 O FNEts OPOM Method 3. - Y1 O O o= \. POMO OH O O NH RCH-OH (PMP2PP- |-OPOM / O NH Ph3P, (EtOC)N RCH-O-PQ R V OPOM R 0009 Scheme 2: Three methods to introduce Bis(POM) phospho-(D)-Ser-l(Z)CHFCPro compounds phosphate O.Y O. SUMMARY OF THE INVENTION -O1 0010. The invention in one preferred embodiment pro vides an alkene compound, selected from the group consist ing of Ac-Phe-Tyr-phosphoSer-CH=C-Pro-Arg-NH2: R H Fmoc-bis(pivaloylmethoxy)phosphoSer-CH=C-Pro-2- N N aminoethyl-(3-indole); Phospho-(D)-serine mimic Ac-Phe R Tyr-phospho-(D)-Ser-CH=C-Pro-Arg-NH and Phos pho-(D)-serine mimic Fmoc-bis(pivaloylmethoxy)phospho phospho-(D)-Ser-I(E)CHFCPro compounds (D)-Ser-CH=C-Pro-2-aminoethyl-(3-indole); wherein I means a pseudo amide. In inventive phospho compounds, (Z) Stereochemistry is preferred, such as, e.g., Ac-Phe-Tyr wherein R is a carbonyl group attached to the amine as an phosphoSer-PI(Z)CH=C-Pro-Arg-NH and Fmoc-bis(piv amide, and R is an amine attached to the carbonyl as an aloylmethoxy)phosphoSer-II (Z)CH=C-Pro-2-aminoet amide. hyl-(3-indole). Other preferred examples of inventive 0013. In the inventive alkene compounds, optionally the phospho compounds, are, e.g., a compound having inhibitory phosphate group is masked as a bis(POM) phosphotriester, activity against Pin1; a compound inhibiting the PPIase activ Such as, e.g., the following alkene compounds: ity of Pin1; a compound that inhibits the growth of cancer cells; etc. 0011. In another preferred embodiment, the invention pro O vides an alkene compound, wherein the alkene compound is O selected from the group consisting of: 1No / N 2 O P O NH y O N R phosphoSer-I(Z)CHFCPro compounds bis(pivaloylmethoxy)phosphoSer-I(Z)CHFCPro compounds US 2008/0261923 A1 Oct.
Load more

Recommended publications
  • Pin1 Inhibitors: Towards Understanding the Enzymatic
    Pin1 Inhibitors: Towards Understanding the Enzymatic Mechanism Guoyan Xu Dissertation submitted to the faculty of the Virginia Polytechnic Institute and State University In the partial fulfillment of the requirement for the degree of Doctor of Philosophy In Chemistry Felicia A Etzkorn, Chair David G. I. Kingston Neal Castagnoli Paul R. Carlier Brian E. Hanson May 6, 2010 Blacksburg, Virginia Keywords: Pin1, anti-cancer drug target, transition-state analogues, ketoamides, ketones, reduced amides, PPIase assay, inhibition Pin1 Inhibitors: Towards Understanding the Enzymatic Mechanism Guoyan Xu Abstract An important role of Pin1 is to catalyze the cis-trans isomerization of pSer/Thr- Pro bonds; as such, it plays an important role in many cellular events through the effects of conformational change on the function of its biological substrates, including Cdc25, c- Jun, and p53. The expression of Pin1 correlates with cyclin D1 levels, which contributes to cancer cell transformation. Overexpression of Pin1 promotes tumor growth, while its inhibition causes tumor cell apoptosis. Because Pin1 is overexpressed in many human cancer tissues, including breast, prostate, and lung cancer tissues, it plays an important role in oncogenesis, making its study vital for the development of anti-cancer agents. Many inhibitors have been discovered for Pin1, including 1) several classes of designed inhibitors such as alkene isosteres, non-peptidic, small molecular Pin1 inhibitors, and indanyl ketones, and 2) several natural products such as juglone, pepticinnamin E analogues, PiB and its derivatives obtained from a library screen. These Pin1 inhibitors show promise in the development of novel diagnostic and therapeutic anticancer drugs due to their ability to block cell cycle progression.
    [Show full text]
  • Anti-Inflammatory Role of Curcumin in LPS Treated A549 Cells at Global Proteome Level and on Mycobacterial Infection
    Anti-inflammatory Role of Curcumin in LPS Treated A549 cells at Global Proteome level and on Mycobacterial infection. Suchita Singh1,+, Rakesh Arya2,3,+, Rhishikesh R Bargaje1, Mrinal Kumar Das2,4, Subia Akram2, Hossain Md. Faruquee2,5, Rajendra Kumar Behera3, Ranjan Kumar Nanda2,*, Anurag Agrawal1 1Center of Excellence for Translational Research in Asthma and Lung Disease, CSIR- Institute of Genomics and Integrative Biology, New Delhi, 110025, India. 2Translational Health Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, 110067, India. 3School of Life Sciences, Sambalpur University, Jyoti Vihar, Sambalpur, Orissa, 768019, India. 4Department of Respiratory Sciences, #211, Maurice Shock Building, University of Leicester, LE1 9HN 5Department of Biotechnology and Genetic Engineering, Islamic University, Kushtia- 7003, Bangladesh. +Contributed equally for this work. S-1 70 G1 S 60 G2/M 50 40 30 % of cells 20 10 0 CURI LPSI LPSCUR Figure S1: Effect of curcumin and/or LPS treatment on A549 cell viability A549 cells were treated with curcumin (10 µM) and/or LPS or 1 µg/ml for the indicated times and after fixation were stained with propidium iodide and Annexin V-FITC. The DNA contents were determined by flow cytometry to calculate percentage of cells present in each phase of the cell cycle (G1, S and G2/M) using Flowing analysis software. S-2 Figure S2: Total proteins identified in all the three experiments and their distribution betwee curcumin and/or LPS treated conditions. The proteins showing differential expressions (log2 fold change≥2) in these experiments were presented in the venn diagram and certain number of proteins are common in all three experiments.
    [Show full text]
  • Role of Protein Repair Enzymes in Oxidative Stress Survival And
    Shome et al. Annals of Microbiology (2020) 70:55 Annals of Microbiology https://doi.org/10.1186/s13213-020-01597-2 REVIEW ARTICLE Open Access Role of protein repair enzymes in oxidative stress survival and virulence of Salmonella Arijit Shome1* , Ratanti Sarkhel1, Shekhar Apoorva1, Sonu Sukumaran Nair2, Tapan Kumar Singh Chauhan1, Sanjeev Kumar Bhure1 and Manish Mahawar1 Abstract Purpose: Proteins are the principal biomolecules in bacteria that are affected by the oxidants produced by the phagocytic cells. Most of the protein damage is irreparable though few unfolded proteins and covalently modified amino acids can be repaired by chaperones and repair enzymes respectively. This study reviews the three protein repair enzymes, protein L-isoaspartyl O-methyl transferase (PIMT), peptidyl proline cis-trans isomerase (PPIase), and methionine sulfoxide reductase (MSR). Methods: Published articles regarding protein repair enzymes were collected from Google Scholar and PubMed. The information obtained from the research articles was analyzed and categorized into general information about the enzyme, mechanism of action, and role played by the enzymes in bacteria. Special emphasis was given to the importance of these enzymes in Salmonella Typhimurium. Results: Protein repair is the direct and energetically preferred way of replenishing the cellular protein pool without translational synthesis. Under the oxidative stress mounted by the host during the infection, protein repair becomes very crucial for the survival of the bacterial pathogens. Only a few covalent modifications of amino acids are reversible by the protein repair enzymes, and they are highly specific in activity. Deletion mutants of these enzymes in different bacteria revealed their importance in the virulence and oxidative stress survival.
    [Show full text]
  • Cyclophilins and Other Foldases: Cell Signaling Catalysts and Drug Targets
    International Symposium on Cyclophilins and other Foldases: Cell Signaling Catalysts and Drug Targets Halle (Saale), Germany, September 19-21, 2013 CONFERENCE MATERIAL Cyclophilins and other Foldases CONFERENCE VENUE The symposium will be held at the Martin-Luther-University Halle-Wittenberg Lecture hall XXII Universitätsplatz 1 06108 Halle (Saale) Germany Conference office telephone: 0157-30056381 2 Cyclophilins and other Foldases CONFERENCE VENUE LOCATION 3 Cyclophilins and other Foldases ORGANIZING COMMITTEE Jochen Balbach (MLU Halle-Wittenberg) Gunter Fischer (MPI BPC Göttingen, BO Halle) Franz X. Schmid (University of Bayreuth) The conference is supported by SCYNEXIS Inc. Selcia Ltd. AstraZeneca Takeda Pharma Debiopharm Fonds der Chemischen Industrie The City of Halle 4 Cyclophilins and other Foldases WELCOME TO THE CONFERENCE We take great pleasure in setting aside our regular lab work and welcoming you all to the International Conference on Cyclophilins and other Foldases - Cell Signaling Catalysts and Drug Targets, which will be held at the Martin-Luther-University Halle- Wittenberg, Germany from September 19th to 22th, 2013. In the last few years, the scientific and biotechnological communities have become increasingly interested in the challenges involved in conformational regulation of bioactivities by endogenous factors such as foldases. This is reflected in the number of over 600 papers published during 2012 about the enzymes addressed in this conference. We are just beginning to understand how catalyzed conformational interconversions of peptide bonds may affect protein functioning under physiological and pathophysiological conditions. This conference is thought to provide an unique forum for researchers to present and exchange new data and to call attention on all aspects of foldase enzymes and their inhibitors.
    [Show full text]
  • Transcriptomic Analysis of Cortical Versus Cancellous Bone in Response to Mechanical Loading and Estrogen Signaling
    TRANSCRIPTOMIC ANALYSIS OF CORTICAL VERSUS CANCELLOUS BONE IN RESPONSE TO MECHANICAL LOADING AND ESTROGEN SIGNALING A Dissertation Presented to the Faculty of the Graduate School of Cornell University In Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy by Natalie H Kelly January 2017 © 2017 Natalie H Kelly TRANSCRIPTOMIC ANALYSIS OF CORTICAL VERSUS CANCELLOUS BONE IN RESPONSE TO MECHANICAL LOADING AND ESTROGEN SIGNALING Natalie H Kelly, Ph. D. Cornell University 2017 Osteoporosis is a skeletal disease characterized by low bone mass that often results in fracture. Mechanical loading of the skeleton is a promising approach to maintain or recover bone mass. Mouse models of in vivo loading differentially increase bone mass in cortical and cancellous sites. The molecular mechanisms behind this anabolic response to mechanical loading need to be determined and compared between cortical and cancellous bone. This knowledge could enhance the development of drug therapies to increase bone formation in osteoporotic patients. After developing a method to isolate high-quality RNA from marrow- free mouse cortical and cancellous bone, differences in gene transcription were determined at baseline and at two time points following mechanical loading of wild-type mice. Cortical and cancellous bone exhibited different transcriptional profiles at baseline and in response to mechanical loading. Enhanced Wnt signaling dominated the response in cortical bone at both time points, but in cancellous bone only at the early time point. In cancellous bone at the later time point, many muscle-related genes were downregulated. Decreased bioavailable estrogen levels are a major cause of bone loss in postmenopausal women.
    [Show full text]
  • Cyclophilin a Catalyzes Proline Isomerization by an Electrostatic Handle Mechanism
    Cyclophilin A catalyzes proline isomerization by an electrostatic handle mechanism Carlo Camillonia, Aleksandr B. Sahakyana, Michael J. Hollidayb, Nancy G. Isernc, Fengli Zhangd, Elan Z. Eisenmesserb, and Michele Vendruscoloa,1 aDepartment of Chemistry, University of Cambridge, Cambridge CB2 1EW, United Kingdom; bDepartment of Biochemistry and Molecular Genetics, University of Colorado, Aurora, CO 80045; cWilliam R. Wiley Environmental Molecular Sciences Laboratory, High Field NMR Facility, Richland, WA 99532; and dNational High Magnetic Field Laboratory, Tallahassee, FL 32310 Edited by Arieh Warshel, University of Southern California, Los Angeles, CA, and approved June 3, 2014 (received for review March 5, 2014) Proline isomerization is a ubiquitous process that plays a key role residue in the substrate and induces the rotation of the electric in the folding of proteins and in the regulation of their functions. dipole corresponding to the carbonyl group of the residue pre- Different families of enzymes, known as “peptidyl-prolyl isomer- ceding the proline. In this sense, the carbonyl group represents ases” (PPIases), catalyze this reaction, which involves the intercon- a handle operated by an electrostatic field and helps overcome version between the cis and trans isomers of the N-terminal amide the isomerization barrier. bond of the amino acid proline. However, complete descriptions of We investigated the conformational properties of cyclophilin the mechanisms by which these enzymes function have remained A during the proline isomerization process by using NMR elusive. We show here that cyclophilin A, one of the most common spectroscopy, which can provide atomic-resolution descriptions PPIases, provides a catalytic environment that acts on the sub- of the motions of macromolecules in solution (24–32).
    [Show full text]
  • Inhibition of the FKBP Family of Peptidyl Prolyl Isomerases Induces Abortive Translocation and Degradation of the Cellular Prion Protein
    Inhibition of the FKBP Family of Peptidyl Prolyl Isomerases Induces Abortive Translocation and Degradation of the Cellular Prion Protein by Maxime Sawicki A thesis submitted in conformity with the requirements for the degree of Master of Science Department of Biochemistry University of Toronto © Copyright by Maxime Sawicki 2015 Inhibition of the FKBP Family of Peptidyl Prolyl Isomerases Induces Abortive Translocation and Degradation of the Cellular Prion Protein Maxime Sawicki Master of Science Department of Biochemistry University of Toronto 2015 Abstract Prion disorders are a class of neurodegenerative diseases that feature a structural change of the prion protein from its cellular form (PrPC) into its scrapie form (PrPSc). As these disorders are currently incurable, there is a crucial need for novel therapeutic agents. Here, the FDA-approved immunosuppressive drug FK506 was shown to cause an attenuation in the endoplasmic reticulum (ER) translocation of PrPC by exacerbating an intrinsic inefficiency of PrP’s ER-targeting signal sequence, effectively causing the proteasomal degradation of PrPC. Furthermore, the depletion of FKBP10 also caused the degradation of PrPC but at a later stage following translocation into the ER. Additionally, novel FK506 analogues with reduced immunosuppressive properties were shown to be as efficacious as FK506 in downregulating PrPC. Finally, both FK506 treatment and FKBP10 depletion were shown to reduce the levels of PrPSc in chronically infected cell models. These findings offer a new insight into the development of treatments against prion disorders. ii Acknowledgments The completion of the present thesis would not have been possible without the help and support of a number of people. First and foremost, I would like to thank my supervisor, Dr David Williams, for his constant guidance and expertise that allowed me to successfully complete my degree, as well as my committee members, Dr John Glover and Dr Gerold Schmitt-Ulms, for their invaluable advice and suggestions over the course of this project.
    [Show full text]
  • Cyclophilins As Modulators of Viral Replication
    Viruses 2013, 5, 1684-1701; doi:10.3390/v5071684 OPEN ACCESS viruses ISSN 1999-4915 www.mdpi.com/journal/viruses Review Cyclophilins as Modulators of Viral Replication Stephen D. Frausto, Emily Lee and Hengli Tang * Department of Biological Science, The Florida State University, Tallahassee, FL 32306, USA; E-Mails: [email protected] (S.D.F); [email protected] (E.L.) * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +1-850-645-2402; Fax: +1-850-645-8447. Received: 22 May 2013; in revised form: 26 June 2013 / Accepted: 3 July 2013 / Published: 11 July 2013 Abstract: Cyclophilins are peptidyl‐prolyl cis/trans isomerases important in the proper folding of certain proteins. Mounting evidence supports varied roles of cyclophilins, either positive or negative, in the life cycles of diverse viruses, but the nature and mechanisms of these roles are yet to be defined. The potential for cyclophilins to serve as a drug target for antiviral therapy is evidenced by the success of non-immunosuppressive cyclophilin inhibitors (CPIs), including Alisporivir, in clinical trials targeting hepatitis C virus infection. In addition, as cyclophilins are implicated in the predisposition to, or severity of, various diseases, the ability to specifically and effectively modulate their function will prove increasingly useful for disease intervention. In this review, we will summarize the evidence of cyclophilins as key mediators of viral infection and prospective drug targets. Keywords: cyclosporin; HIV; HCV; cyclophilin 1. Introduction Unlike other infective agents, viruses do not encode a full complement of proteins that allow them to proliferate independent of the host.
    [Show full text]
  • Structure and Function of Per-ARNT-Sim Domains and Their Possible Role in the Life-Cycle Biology of Trypanosoma Cruzi
    Accepted Manuscript Title: Structure and function of Per-ARNT-Sim domains and their possible role in the life-cycle biology of Trypanosoma cruzi Authors: Maura Rojas-Pirela, Daniel J. Rigden, Paul A. Michels, Ana J. Caceres,´ Juan Luis Concepcion,´ Wilfredo Quinones˜ PII: S0166-6851(17)30135-4 DOI: https://doi.org/10.1016/j.molbiopara.2017.11.002 Reference: MOLBIO 11096 To appear in: Molecular & Biochemical Parasitology Received date: 30-4-2017 Revised date: 12-10-2017 Accepted date: 2-11-2017 Please cite this article as: Rojas-Pirela Maura, Rigden Daniel J, Michels Paul A, Caceres´ Ana J, Concepcion´ Juan Luis, Quinones˜ Wilfredo.Structure and function of Per-ARNT-Sim domains and their possible role in the life- cycle biology of Trypanosoma cruzi.Molecular and Biochemical Parasitology https://doi.org/10.1016/j.molbiopara.2017.11.002 This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. Review Structure and function of Per-ARNT-Sim domains and their possible role in the life-cycle biology of Trypanosoma cruzi Maura Rojas-Pirelaa, Daniel J. Rigdenb, Paul A. Michelsc, Ana J. Cáceresa, Juan Luis Concepcióna, Wilfredo Quiñonesa,* a Laboratorio de Enzimología de Parásitos, Departamento de Biología, Facultad de Ciencias, Universidad de Los Andes, Mérida 5101, Venezuela b Institute of Integrative Biology, University of Liverpool, Liverpool, L69 7ZB, United Kingdom.
    [Show full text]
  • Genetic Diversity in Proteolytic Enzymes and Amino Acid Metabolism Among Lactobacillus Helveticus Strains1
    J. Dairy Sci. 94 :4313–4328 doi: 10.3168/jds.2010-4068 © American Dairy Science Association®, 2011 . Genetic diversity in proteolytic enzymes and amino acid metabolism among Lactobacillus helveticus strains1 J. R. Broadbent ,*2 H. Cai ,† R. L. Larsen ,* J. E. Hughes ,‡ D. L. Welker ,‡ V. G. De Carvalho ,§ T. A. Tompkins ,§ DQG-/6WHHOHۅ1HYLDQL)ۅDWWL*0ۅUG|)9RJHQVHQ$'H/RUHQWLLV$> * Department of Nutrition, Dietetics, and Food Sciences and Western Dairy Center, Utah State University, Logan 84322-8700 † Department of Food Science, University of Wisconsin–Madison 53706 ‡ Department of Biology, Utah State University, Logan 84322-5305 § Institut Rosell, Montreal, QC, Canada H4P 2R2 # University of Copenhagen, Rolighedsvej 30, DK-1958 Frederiksberg C, Denmark \HSDUWPHQWRI*HQHWLFV%LRORJ\RI0LFURRUJDQLVPV$QWKURSRORJ\(YROXWLRQ8QLYHUVLW\RI3DUPD9LDOH8VEHUWL$3DUPD,WDO'ۅ ABSTRACT and Sjöström, 1975; Bartels et al., 1987a,b; Ardö and Pettersson, 1988; Drake et al., 1996). Moreover, milk Lactobacillus helveticus CNRZ 32 is recognized for fermented with certain Lb. helveticus strains has been its ability to decrease bitterness and accelerate flavor shown to become enriched with antihypertensive and development in cheese, and has also been shown to immunomodulatory bioactive peptides (Laffineur et al., release bioactive peptides in milk. Similar capabilities 1996; LeBlanc et al., 2002; Hayes et al., 2007b; Gob- have been documented in other strains of Lb. helveticus, betti et al., 2010). Although Lb. helveticus is commonly but the ability of different strains to affect these char- associated with milk environments, this species has also acteristics can vary widely. Because these attributes been recovered from whisky fermentations (Cachat and are associated with enzymes involved in proteolysis Priest 2005; Naser et al.
    [Show full text]
  • International Conference on Gram-Positive Pathogens
    International Conference on G r a m - Positive Pathogens 6th Meeting + October 9-12 2016 + Omaha, NE 2 W e lc o m e to the International Conference on Gram-Positive Pathogens (ICG+P)! We are very pleased you have travelled to Omaha to join us and we hope that you have a relaxing, yet intellectually stimulating meeting. Infections caused by gram-positive pathogens, including Staphylococcus aureus, Streptococcus pyogenes, Clostridium difficile, and Enterococcus faecium, among others, are a burden on our society causing significant morbidity and mortality. This conference seeks to better understand these bacteria through fostering interactions between investigators studying multiple aspects of gram-positive pathogenesis, biology, and host defense. Another important aspect of the ICG+P is the active support of pre- and post-doctoral trainees; most oral presentations are awarded to trainees or junior faculty. Ultimately, the goal of this conference is to broaden our understanding of gram-positive pathogenesis and biology through the generation of new collaborations and to gain new insights through the study of similar systems in these related pathogens. Finally, we are very excited to have the following four keynote presentations: Sunday, October 9th 7:15-8:15 pm Dr. Ken Bayles, Professor and Associate Vice Chancellor for Basic Science Research in the Department of Pathology & Microbiology at the University of Nebraska Medical Center in Omaha, NE “Staphylococcus aureus biofilm development and the origins of multicellularity.” Monday October 10th 8:00-9:00 am Dr. Gary Dunny, Professor in the Department of Microbiology and Immunology at the University of Minnesota in St. Paul, MN “Sensing, adaptation and competitive fitness in E.
    [Show full text]
  • Roles of Peptidyl-Prolyl Isomerase Pin1 in Disease Pathogenesis
    Theranostics 2021, Vol. 11, Issue 7 3348 Ivyspring International Publisher Theranostics 2021; 11(7): 3348-3358. doi: 10.7150/thno.45889 Review Roles of peptidyl-prolyl isomerase Pin1 in disease pathogenesis Jingyi Li1,2*, Chunfen Mo3*, Yifan Guo2, Bowen Zhang1, Xiao Feng2, Qiuyue Si2, Xiaobo Wu2, Zhe Zhao2, Lixin Gong1, Dan He1 and Jichun Shao1 1. The Second Affiliated Hospital of Chengdu Medical College, China National Nuclear Corporation 416 Hospital, Chengdu, Sichuan, China. 2. School of Biological Sciences and Technology, Chengdu Medical College, Chengdu, China. 3. Department of Immunology, School of Basic Medical Sciences, Chengdu Medical College, Chengdu, China. *These authors contributed equally to this work. Corresponding authors: Jingyi Li, Jichun Shao and Dan He, The Second Affiliated Hospital of Chengdu Medical College, China National Nuclear Corporation 416 Hospital, Chengdu, Sichuan, China. E-mail: [email protected]; [email protected]; [email protected]. © The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. Received: 2020.03.11; Accepted: 2020.12.02; Published: 2021.01.19 Abstract Pin1 belongs to the peptidyl-prolyl cis-trans isomerases (PPIases) superfamily and catalyzes the cis-trans conversion of proline in target substrates to modulate diverse cellular functions including cell cycle progression, cell motility, and apoptosis. Dysregulation of Pin1 has wide-ranging influences on the fate of cells; therefore, it is closely related to the occurrence and development of various diseases. This review summarizes the current knowledge of Pin1 in disease pathogenesis.
    [Show full text]